Aberrant expression of miR-17-92 plays an important oncogenic role in aggressive SCLC cells through the regulation of downstream target genes, such as PTEN, P21, Bim, and E2F [32]. The gene discussed is CDKN1A; the disease is small cell lung carcinoma.